Finally, in systemic sclerosis, TNF-α was found to be elevated in SSc patients, and its higher serum levels, influenced by specific TNFA gene promoter polymorphisms, correlate with an increased risk of cancer in these patients [41]. This evidence concerns the gene TNF and systemic sclerosis.